相关实验视频
Updated: Jun 23, 2025

07:09
The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
48.2K
米罗加巴林作为神经病痛治疗的治疗选择 新兴的内牙后治疗:两例病例报告
Kohei Shimizu1, Takuya Yasukawa1, Kinuyo Ohara1
1Department of Endodontics, Nihon University School of Dentistry, Tokyo, Japan; Division of Advanced Dental Treatment, Dental Research Center, Nihon University School of Dentistry, Tokyo, Japan.
Journal of endodontics
|June 20, 2024
概括
在内牙后的神经病痛可以有效地用米罗加巴林治疗. 这种药物在两种情况下显著降低了疼痛,为牙科手术后持续不适的患者提供了新的治疗选择.
科学领域:
- 牙科 牙科是指牙科的专业.
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 牙周内后的疼痛,特别是闭合性和打击性疼痛,可以影响重新治疗的决定.
- 介绍了两种被归类为创伤后三角神经病痛的近周神经病痛病例.
- 米罗加巴林在神经病痛治疗中表现出有效性,但其在内牙后三角关节疼痛中的使用报告不足.
研究的目的:
- 在内治疗后呈现创伤后三角神经病痛的临床病例.
- 为了评估米罗加巴林在治疗这种特定类型神经病痛方面的疗效.
- 为临床医生提供潜在的新治疗策略.
主要方法:
- 患者呈现出持续的闭塞和冲击疼痛,对抗生素或NSAIDs没有反应.
- 诊断评估,包括局部麻醉测试和成像,排除了其他病理.
- 进行了内牙治疗,随后开出了米罗加巴林 (10毫克/天) 的处方.
主要成果:
- 米罗加巴林治疗导致视觉模拟尺度疼痛评分在两周内显著和逐渐下降.
- 患者在停止服用米罗加巴林后几个月经历了持续的疼痛缓解.
- 在停止治疗后,没有发现牙内后疼痛的复发.
结论:
- 米罗加巴林是一种可行的治疗选择,用于在内手术后的创伤后三角神经病痛.
- 这些病例表明一种新的治疗方法,用于管理在内牙科的持续性神经病痛.
- 临床医生可以考虑米罗加巴林用于具有类似表现的患者.
相关概念视频
Analgesia and Pain Management
575
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
575
Opioid Analgesics: Synthetic and Semisynthetic Opioids
275
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
275
Antiepileptic Drugs: Potassium Channel Activators
169
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
169

